(Q44021066)

English

Protective effect of Tanshinone IIA against infarct size and increased HMGB1, NFκB, GFAP and apoptosis consequent to transient middle cerebral artery occlusion

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Protective effect of Tanshinone IIA against infarct size and increased HMGB1, NFκB, GFAP and apoptosis consequent to transient middle cerebral artery occlusion (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Jian-Gang Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Stephen C Bondy

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Li Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Feng-Zhen Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Zhi-Gang Ding

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yu Hu

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yun Tian

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pu-Yuan Wen

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hao Luo

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Fang Wang

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Wen-Wen Li

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jun Zhou

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

23 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Neurochemical Research

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

295-304

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

https://scigraph.springernature.com/pub.10.1007/s11064-013-1221-y

0 references

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Caspase-independent programmed cell death following ischemic stroke

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Transient cerebral ischemia induces active astrocytosis without distinct neuronal death in the gerbil main olfactory bulb: a long-term analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Therapeutic hypothermia for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

New neurons in an aged brain

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

The neuroprotective effects of Tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Reversible middle cerebral artery occlusion without craniectomy in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

The HMGB1 receptor RAGE mediates ischemic brain damage

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

High mobility group box 1 protein interacts with multiple Toll-like receptors

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

The protective effects of tanshinone IIA on β-amyloid protein (1-42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Early release of HMGB-1 from neurons after the onset of brain ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

NF-kappaB signaling in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

HMG1 and 2, and related 'architectural' DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

High mobility group 1 B-box mediates activation of human endothelium

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Tanshinones inhibit amyloid aggregation by amyloid-β peptide, disaggregate amyloid fibrils, and protect cultured cells

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and rat.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

Paeonol increases levels of cortical cytochrome oxidase and vascular actin and improves behavior in a rat model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1221-Y

21 January 2018

High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24362639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24362639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/24362639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge

1 reference

https://pubmed.ncbi.nlm.nih.gov/24362639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tanshinone II-A inhibits low density lipoprotein oxidationin vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/24362639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sodium tanshinone iia sulfonate attenuates seawater aspiration-induced acute pulmonary edema by up-regulating Na(+),K(+)-ATPase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24362639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ischemia signalling to Alzheimer-related genes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24362639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11064-013-1221-Y

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44021066&oldid=2105708584"